Skip to Main Content

File this under “Been down so long, looks like up to me.”

Just 43 percent of patient groups thought the pharmaceutical industry had an “excellent” or “good” reputation last year. Despite the poor showing, however, this is still an improvement — albeit, a modest one — from the 38 percent of patient groups that offered the same assessment in 2016, according to PatientView, a research firm that canvassed more than 1,300 patient groups from 95 countries.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

  • It was my intention to say that our scribe tried rather hard to find a positive side to these bleak numbers. Now that I have converted the intention into words, adieu!

  • Well, 38% “excellent” or “good” may be a “poor showing” for drug companies, but it’s no doubt much higher than the rating for journalists.

    • Hi James,

      Thanks for stopping by.

      The report was not an effort undertaken by STAT, but a research firm, as noted in the post. And the survey collected what patient groups think about those few dozen companies.

      I can understand your frustration, but I believe you’re shooting the messenger.

      ed at Pharmalot

Comments are closed.